ANIP Oct 2024 65.000 put
| Previous close | 3.2500 |
| Open | N/A |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 65.00 |
| Expiry date | 2024-10-18 |
| Day's range | 3.2500 - 3.2500 |
| Contract range | N/A |
| Volume | |
| Open interest | 5 |
ZacksImplied Volatility Surging for ANI Pharmaceuticals (ANIP) Stock Options
Investors need to pay close attention to ANI Pharmaceuticals (ANIP) stock based on the movements in the options market lately.
GuruFocus.comInsider Sale: SVP & CFO Stephen Carey Sells 5,000 Shares of ANI Pharmaceuticals Inc (ANIP)
On June 4, 2024, Stephen Carey, Senior Vice President & Chief Financial Officer of ANI Pharmaceuticals Inc (NASDAQ:ANIP), sold 5,000 shares of the company.
GlobeNewswireANI Pharmaceuticals to Present at the 2024 Jefferies Global Healthcare Conference
BAUDETTE, Minn., May 29, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2024 Jefferies Global Healthcare Conference in New York City as follows: Date:June 5, 2024 Time:4:30 ET Webcast:Click Here To schedule a 1x1 meeting with the Company, please contact your Jefferies representative. About ANI Pharmaceuticals, Inc. ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified bio
